Xortx Therapeutics Inc (XRTX)

$0.74 +0.01 (0.79%)
Market Cap 3.07M
Revenue (ttm) 0.00
Net Income (ttm) -3.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 35,342
Avg Vol 118,938
Day's Range N/A - N/A
Shares Out 3.79M
Stochastic %K 4%
Beta 0.51
Analysts Strong Buy
Price Target $14.00

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, w...

Industry: Biotechnology
Sector: Healthcare
Phone: 403-455-7727
Address:
3710 – 33rd Street NW, Calgary, Canada
honestrick
honestrick Jul. 30 at 2:35 PM
$XRTX Is XRTX prime to RIP? $VOR $NAK $PLUG
0 · Reply
warm_it_up
warm_it_up Jul. 29 at 3:40 PM
$XRTX I love how when companies close private placement offerings, companies go up in share price. Not this one though! I'm still gonna hold for gold.
0 · Reply
Joshimi
Joshimi Jul. 28 at 11:54 PM
$XRTX Now do the DRUG thing! Or the VW …
0 · Reply
avoz
avoz Jul. 25 at 8:59 AM
$XRTX
0 · Reply
TheUnmaker
TheUnmaker Jul. 24 at 7:10 PM
$XRTX Shakeout before pump.
0 · Reply
LookaLike
LookaLike Jul. 23 at 4:23 PM
$XRTX small offering closed, now we wait for news to go up
0 · Reply
ThebookofEli
ThebookofEli Jul. 17 at 11:51 PM
$XRTX i like the setup
1 · Reply
taxidriver514
taxidriver514 Jul. 17 at 6:38 PM
$XRTX @ACInvestorBlog @dbr_island @ProfessorDman1
0 · Reply
LookaLike
LookaLike Jul. 17 at 6:20 PM
$XRTX we just need a spike to 15$ without a reason like $CYCC
0 · Reply
taxidriver514
taxidriver514 Jul. 17 at 5:29 PM
$XRTX
0 · Reply
Latest News on XRTX
XORTX Completes Non-Brokered Private Placement of Units

Jul 22, 2025, 7:59 PM EDT - 7 days ago

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $925,000 Private Placement

Jun 26, 2025, 7:00 AM EDT - 4 weeks ago

XORTX Announces USD $925,000 Private Placement

XORTX Announces USD $3 Million Offering

May 19, 2025, 7:00 AM EDT - 2 months ago

XORTX Announces USD $3 Million Offering

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Apr 17, 2025, 7:45 PM EDT - 3 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Change of Auditor

Jan 17, 2025, 5:00 PM EST - 6 months ago

XORTX Announces Change of Auditor

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Dec 12, 2024, 9:17 AM EST - 8 months ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 4:00 PM EDT - 10 months ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

Oct 9, 2024, 5:00 AM EDT - 10 months ago

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

Sep 13, 2024, 7:00 AM EDT - 11 months ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Sep 12, 2024, 5:30 PM EDT - 11 months ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Sep 6, 2024, 5:30 PM EDT - 11 months ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Sep 3, 2024, 12:30 PM EDT - 11 months ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Aug 23, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

Aug 20, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

May 17, 2024, 7:00 AM EDT - 1 year ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Apr 30, 2024, 1:54 PM EDT - 1 year ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

Apr 22, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

Apr 8, 2024, 7:30 AM EDT - 1 year ago

XORTX Welcomes New Member to the Board of Directors

XORTX Announces New Clinical Advisory Board Member

Mar 27, 2024, 5:00 AM EDT - 1 year ago

XORTX Announces New Clinical Advisory Board Member

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Mar 19, 2024, 5:00 AM EDT - 1 year ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Mar 4, 2024, 7:00 AM EST - 1 year ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Feb 1, 2024, 8:46 PM EST - 1 year ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

XORTX Announces $2 Million Public Offering

Jan 15, 2024, 7:00 AM EST - 1 year ago

XORTX Announces $2 Million Public Offering

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Jan 3, 2024, 7:00 AM EST - 1 year ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Announces US ATM Offering

Nov 30, 2023, 7:30 AM EST - 1 year ago

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

Nov 29, 2023, 7:00 AM EST - 1 year ago

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

Nov 10, 2023, 7:00 AM EST - 1 year ago

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Share Consolidation

Nov 8, 2023, 5:00 PM EST - 1 year ago

XORTX Announces Share Consolidation

XORTX Announces Results of Special Meeting of Shareholders

Oct 27, 2023, 5:30 PM EDT - 1 year ago

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 1 year ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 1 year ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 12, 2023, 7:00 AM EDT - 1 year ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

XORTX Calls Special Meeting of Shareholders

Oct 4, 2023, 7:00 AM EDT - 1 year ago

XORTX Calls Special Meeting of Shareholders

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

Aug 29, 2023, 7:00 AM EDT - 2 years ago

XORTX Submits Orphan Drug Designation Application to the European Medicines Agency (EMA) to Treat Progressive Kidney Disease

XORTX Appoints Chief Financial Officer

Aug 4, 2023, 5:00 PM EDT - 2 years ago

XORTX Appoints Chief Financial Officer

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

Jun 23, 2023, 8:51 PM EDT - 2 years ago

XORTX Reminds Shareholders to Vote ahead of the Proxy Voting Deadline for the Company's Upcoming Annual and Special Meeting of Shareholders

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

May 24, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

Apr 21, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Receipt of FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

Feb 1, 2023, 7:00 AM EST - 2 years ago

XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

Jan 19, 2023, 7:00 AM EST - 2 years ago

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Dec 8, 2022, 7:00 AM EST - 2 years ago

XORTX Announces New Proof of Concept Data in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

Nov 28, 2022, 7:00 AM EST - 2 years ago

XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Nov 25, 2022, 5:45 PM EST - 2 years ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

Nov 16, 2022, 7:00 AM EST - 2 years ago

XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer

XORTX Presents New Proof of Concept Data at American Society of Nephrology

Nov 3, 2022, 5:00 PM EDT - 2 years ago

XORTX Presents New Proof of Concept Data at American Society of Nephrology

XORTX Announces Participation at Upcoming Investor Conferences

Nov 3, 2022, 10:15 AM EDT - 2 years ago

XORTX Announces Participation at Upcoming Investor Conferences

XORTX Announces Closing of US$5 Million Public Offering

Oct 7, 2022, 6:02 PM EDT - 3 years ago

XORTX Announces Closing of US$5 Million Public Offering

XORTX Announces US$5 Million Public Offering

Oct 4, 2022, 8:30 AM EDT - 3 years ago

XORTX Announces US$5 Million Public Offering

XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration

Sep 19, 2022, 7:00 AM EDT - 3 years ago

XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration

XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study

Aug 22, 2022, 7:00 AM EDT - 3 years ago

XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study

honestrick
honestrick Jul. 30 at 2:35 PM
$XRTX Is XRTX prime to RIP? $VOR $NAK $PLUG
0 · Reply
warm_it_up
warm_it_up Jul. 29 at 3:40 PM
$XRTX I love how when companies close private placement offerings, companies go up in share price. Not this one though! I'm still gonna hold for gold.
0 · Reply
Joshimi
Joshimi Jul. 28 at 11:54 PM
$XRTX Now do the DRUG thing! Or the VW …
0 · Reply
avoz
avoz Jul. 25 at 8:59 AM
$XRTX
0 · Reply
TheUnmaker
TheUnmaker Jul. 24 at 7:10 PM
$XRTX Shakeout before pump.
0 · Reply
LookaLike
LookaLike Jul. 23 at 4:23 PM
$XRTX small offering closed, now we wait for news to go up
0 · Reply
ThebookofEli
ThebookofEli Jul. 17 at 11:51 PM
$XRTX i like the setup
1 · Reply
taxidriver514
taxidriver514 Jul. 17 at 6:38 PM
$XRTX @ACInvestorBlog @dbr_island @ProfessorDman1
0 · Reply
LookaLike
LookaLike Jul. 17 at 6:20 PM
$XRTX we just need a spike to 15$ without a reason like $CYCC
0 · Reply
taxidriver514
taxidriver514 Jul. 17 at 5:29 PM
$XRTX
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 14 at 11:34 AM
$DVLT coding the 1.65* among other zones using parts of your chart for the market will impact $PRSO side note $XRTX. and $THAR indirectly
0 · Reply
TheUnmaker
TheUnmaker Jul. 12 at 3:57 PM
$XRTX
0 · Reply
taxidriver514
taxidriver514 Jul. 11 at 4:03 PM
$XRTX @DougieFreshPicks
0 · Reply
avoz
avoz Jul. 11 at 3:47 PM
$XRTX
0 · Reply
taxidriver514
taxidriver514 Jul. 11 at 3:35 PM
$XRTX
0 · Reply
BearTamerTrading
BearTamerTrading Jul. 4 at 3:52 PM
Happy 4th of July, traders 🇺🇸🔥 In the spirit of freedom… I’m giving my service away for FREE. Just kidding—it’s always FREE 😎. Join a community where we learn, earn, and grow together.✅ Real results.✅ Free plays.✅ Daily action.Check my pinned post for proof. Subscribe now and don’t miss the next breakout: https://youtube.com/@beartamertrading?si=tXbe9QBkY2wvxxTq $KNW $AEBI $MIRA $MPU $SGMT $SEPN $VERO $XRTX $IINN $PMAX $GNS $LIMN $OSTX $OGEN $AEI $LRHC $CLBR $SOFI $BBAI $GNLN $UAMY $SAFX $PRSO $FEMY $ILLR $BMNR $GITS $RGC $EGG $WOLF $LIXT $JUNS $THTX $XPOF $VOR
0 · Reply
LookaLike
LookaLike Jul. 3 at 5:19 PM
$XRTX big volume without news. Maybe some big investors loading the boat hopefully
0 · Reply
honestrick
honestrick Jul. 3 at 3:40 PM
$XRTX Still
0 · Reply
LookaLike
LookaLike Jul. 3 at 2:14 PM
$XRTX any news? I cant find anything
0 · Reply
honestrick
honestrick Jul. 3 at 1:39 PM
$XRTX There were big share trades in the $1.20 to $1.40 ra2nge this morning i think around 8.24 am hoping for a close there
0 · Reply
warm_it_up
warm_it_up Jul. 3 at 1:04 PM
$XRTX what on earth is going on here?
1 · Reply
avoz
avoz Jul. 3 at 12:33 PM
$XRTX Pre-market -17% with over 3 million volume
0 · Reply